Derivative exercise or conversion — not an open-market buy.
Traded Feb 23, 2026 · Filed Feb 24, 2026
Cognex's Global Sales and Products sold $589K of Cognex shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$589,042
Shares × reported transaction price
12 days after results of Feb 11, 2026, 72 days before results of May 6, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −7.4% | −1.2% | −6.2% |
| 30 days | −17.1% | −8.5% | −8.6% |
| 90 days | +19.0% | +8.3% | +10.7% |
| 180 days | +1.9% | +10.1% | −8.2% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
Routine share withholding; mechanical by default.
Derivative exercise or conversion — not an open-market buy.